Development of improved adenosine deaminase retroviral vectors

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 1769-1774

  Onodera, Masafumi ^a   Nelson, David M ^a   Yachie, Akihiro ^b   Jagadeesh, G Jayashree ^a   Bunnell, Bruce A ^a   Morgan, Richard A ^a   Blaese, R Michael ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; VIRUS VECTOR;

ARTICLE; MOLONEY LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; VIRUS EXPRESSION;

EID: 0031888260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.1769-1774.1998     Document Type: Article

References (30)

1. Blaese, R. M., K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J. J. Greenblatt, S. A. Rosenberg, H. Klein, M. Berger, C. A. Mullen, W. J. Ramsey, L. Muul, R. A. Morgan, and W. F. Anderson. 1995. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475-480.
2. Bonini, C., G. Ferrari, S. Verzeletti, P. Servida, E. Zappone, L. Ruggieri, M. Ponzoni, S. Rossini, F. Mavilio, C. Traversari, and C. Bordignon. 1997. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-vs-leukemia. Science 276:1719-1724.
3. Bunnell, B. A., L. M. Muul, R. E. Donahue, R. M. Blaese, and R. A. Morgan. 1995. High-efficiency retroviral-mediated gene transfer into human and non-human primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92:7739-7743.
4. Cone, R. D., and R. C. Mulligan. 1984. High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. USA 81:6349-6353.
5. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
6. Couture, L. A., C. A. Mullen, and R. A. Morgan. 1994. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression. Hum. Gene Ther. 5:667-677.
7. Dunbar, C. E., M. Cottler-Fox, J. A. O'Shaughnessy, S. Doren, C. Carter, R. Berenson, S. Brown, R. C. Moen, J. Greenblatt, F. M. Stewart, S. F. Leitman, W. H. Wilson, K. Cowan, N. S. Young, and A. W. Nienhuis. 1995. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048-3057.
8. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
9. Franz, T., B. Hilberg, B. Seliger, C. Stocking, and W. Ostertag. 1986. Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 83:3292-3296.
10. Guild, B. C., R. C. Mulligan, P. Gros, and D. E. Housman. 1988. Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection. Proc. Natl. Acad. Sci. USA 85:1595-1599.
11. Hock, R. A., A. D. Miller, and W. R. Osborne. 1989. Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74:876-881.
12. Kohn, D. B., H. Mitsuya, M. Ballow, J. E. Selegue, J. Barankiewicz, A. Cohen, E. Gelfand, W. F. Anderson, and R. M. Blaese. 1989. Establishment and characterization of adenosine deaminase-deficient human T cell lines. J. Immunol. 142:3971-3977.
13. Kohn, D. B., K. I. Weinberg, J. A. Nolta, L. N. Heiss, C. Lenarsky, G. M. Crooks, M. E. Hanley, G. Annett, J. S. Brooks, A. el-Khoureiy, K. Lawrence, D. Wells, R. C. Moen, J. Bastian, D. E. Williams-Herman, M. Elder, D. Wara, T. Bowen, M. S. Hershfield, C. A. Mullen, R. M. Blaese, and R. Parkman. 1995. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1:1017-1023.
14. Krall, W. J., D. C. Skelton, X. J. Yu, I. Riviere, P. Lehn, R. C. Mulligan, and D. B. Kohn. 1996. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3:37-48.
15. Marcel, T., and J. Grausz. 1997. The TWC worldwide gene therapy enrollment report, end 1996. Hum. Gene Ther. 8:775-780.
16. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
17. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
18. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
19. Miller, A. D., M. F. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5:431-437.
20. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260:926-932.
21. 20a. Muul, L., and R. M. Blaese. Unpublished data.
22. Ohashi, T., S. Boggs, P. Robbins, A. Bahnson, K. Patrene, F. S. Wei, J. F. Wei, J. Li, L. Lucht, Y. Fei, S. Clark, M. Kimak, H. He, P. Mowery-Rushton, and J. A. Barranger. 1992. Efficient transfer and sustained high expression of the human glucoceregrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc. Natl. Acad. Sci. USA 89:11332-11336.
23. Onodera, M., T. Ariga, N. Kawamura, I. Kobayashi, M. Otsu, M. Yamada, A. Tame, H. Furuta, M. Okano, S. Matsumoto, H. Kotani, G. J. McGarrity, R. M. Blaese, and Y. Sakiyama. 1998. Successful peripheral T lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiency. Blood 91:30-36.
24. Onodera, M., A. Yachie, D. M. Nelson, H. L. Welchlin, R. A. Morgan, and R. M. Blaese. 1997. A simple and reliable method for screening retroviral producer cell clones without selectable markers. Hum. Gene Ther. 8:1189-1194.
25. Pawliuk, R., R. Kay, P. Lansdorp, and R. K. Humphries. 1994. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868-2877.
26. Riddell, S. R., M. Elliott, D. A. Lewinsohn, M. J. Gilbert, L. Wilson, S. A. Manley, S. D. Lupton, R. W. Overell, T. C. Reynolds, L. Corey, and P. D. Greenberg. 1996. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216-223. (Comment.)
27. Riviere, I., K. Brose, and R. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733-6737.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
29. Van Beusechem, V. W., and D. Valerio. 1996. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum. Gene Ther. 7:1649-1668.
30. Xu, L., J. K. Yee, J. A. Wolff, and T. Friedman. 1989. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology 171:331-341.